# Kefir Sleep Healthy Adults Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/kefir-sleep-healthy-adults-randomized-trial-evidence-review
Category: evidence-review
Summary: Kefir Sleep Healthy Adults Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-08-16
Reviewed by: Migaku Evidence Review
# Kefir Sleep Healthy Adults Randomized Trial: What the Evidence Says

## Quick Answer

Kefir Sleep Healthy Adults Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Kefir Consumption and Health Effects Based on Human Clinical Trials: An Overview of Literature | randomized trial | 2 | 2026-03-04 | 10.3390/healthcare14050652 |
| The microbiota–gut–brain axis as a modulator of symptom expression in autism spectrum disorder, with exploratory insights into ADHD: evidence from a structured narrative review on paediatric population | preclinical study | 4 | 2026-05-28 | 10.3389/frcha.2026.1835043 |

## What The Sources Report

- Regular consumption of kefir has been associated with a wide spectrum of benefits, including improved gut health, modulation of intestinal microbiota, enhanced immune function, and protective effects against metabolic, cardiovascular, and gastrointestinal disorders. [Fijan Sabina (2026); evidence level 2]
- Kefir is also associated with high acceptance, particularly regarding its health benefits. [Fijan Sabina (2026); evidence level 2]
- In addition to core behavioral symptoms, both ASD and ADHD are frequently associated with gastrointestinal disturbances, immune dysregulation, metabolic alterations, and atypical dietary patterns, suggesting the involvement of systemic biological pathways interacting with neurodevelopment. [Carta Alessandra (2026); evidence level 4]
- Moreover, both conditions have been associated with alterations in neurotransmitter systems, particularly serotonergic and dopaminergic pathways, which may be influenced by gut microbial signalling through neural, endocrine, immune, and metabolic routes. [Carta Alessandra (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For kefir sleep healthy adults randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Fijan Sabina (2026). Kefir Consumption and Health Effects Based on Human Clinical Trials: An Overview of Literature. DOI: 10.3390/healthcare14050652. PMCID: PMC12984562. PMID: 41827605. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12984562/
- Carta Alessandra (2026). The microbiota–gut–brain axis as a modulator of symptom expression in autism spectrum disorder, with exploratory insights into ADHD: evidence from a structured narrative review on paediatric population. DOI: 10.3389/frcha.2026.1835043. PMCID: PMC13253956. PMID: 42294021. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13253956/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.